Bio-Rad Laboratories (BIO) Competitors $257.34 -2.54 (-0.98%) As of 07/11/2025 03:58 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BIO vs. MTD, WAT, ILMN, TECH, CRL, BRKR, PACB, HBIO, TMO, and AShould you be buying Bio-Rad Laboratories stock or one of its competitors? The main competitors of Bio-Rad Laboratories include Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry. Bio-Rad Laboratories vs. Its Competitors Mettler-Toledo International Waters Illumina Bio-Techne Charles River Laboratories International Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies Bio-Rad Laboratories (NYSE:BIO) and Mettler-Toledo International (NYSE:MTD) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment and earnings. Do analysts prefer BIO or MTD? Bio-Rad Laboratories currently has a consensus target price of $324.25, indicating a potential upside of 26.00%. Mettler-Toledo International has a consensus target price of $1,280.90, indicating a potential upside of 4.68%. Given Bio-Rad Laboratories' stronger consensus rating and higher probable upside, equities analysts plainly believe Bio-Rad Laboratories is more favorable than Mettler-Toledo International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bio-Rad Laboratories 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75Mettler-Toledo International 0 Sell rating(s) 6 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.45 Is BIO or MTD more profitable? Mettler-Toledo International has a net margin of 22.17% compared to Bio-Rad Laboratories' net margin of -85.16%. Bio-Rad Laboratories' return on equity of 4.32% beat Mettler-Toledo International's return on equity.Company Net Margins Return on Equity Return on Assets Bio-Rad Laboratories-85.16% 4.32% 3.03% Mettler-Toledo International 22.17%-556.22%26.27% Do institutionals and insiders have more ownership in BIO or MTD? 65.2% of Bio-Rad Laboratories shares are held by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are held by institutional investors. 17.1% of Bio-Rad Laboratories shares are held by insiders. Comparatively, 1.9% of Mettler-Toledo International shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has preferable valuation and earnings, BIO or MTD? Mettler-Toledo International has higher revenue and earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBio-Rad Laboratories$2.57B2.73-$1.84B-$76.20-3.38Mettler-Toledo International$3.87B6.57$863.14M$40.1030.51 Which has more volatility & risk, BIO or MTD? Bio-Rad Laboratories has a beta of 0.95, suggesting that its share price is 5% less volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.37, suggesting that its share price is 37% more volatile than the S&P 500. Does the media favor BIO or MTD? In the previous week, Mettler-Toledo International had 12 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 19 mentions for Mettler-Toledo International and 7 mentions for Bio-Rad Laboratories. Mettler-Toledo International's average media sentiment score of 1.10 beat Bio-Rad Laboratories' score of 0.31 indicating that Mettler-Toledo International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bio-Rad Laboratories 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Mettler-Toledo International 11 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryMettler-Toledo International beats Bio-Rad Laboratories on 12 of the 16 factors compared between the two stocks. Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIO vs. The Competition Export to ExcelMetricBio-Rad LaboratoriesMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$6.99B$10.56B$5.55B$20.65BDividend YieldN/A2.09%5.07%3.72%P/E Ratio-3.3816.8328.2127.82Price / Sales2.7330.16432.0042.44Price / Cash24.7322.5637.1222.32Price / Book1.103.668.044.57Net Income-$1.84B$235.43M$3.19B$989.30M7 Day Performance2.30%1.27%3.63%0.20%1 Month Performance10.72%2.95%4.06%3.95%1 Year Performance-15.46%-15.74%30.02%10.27% Bio-Rad Laboratories Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIOBio-Rad Laboratories4.58 of 5 stars$257.34-1.0%$324.25+26.0%-12.9%$6.99B$2.57B-3.387,700News CoverageAnalyst RevisionMTDMettler-Toledo International4.1397 of 5 stars$1,188.28-1.7%$1,300.36+9.4%-9.9%$24.69B$3.87B29.6317,300Positive NewsAnalyst ForecastWATWaters4.3471 of 5 stars$346.35-1.1%$388.00+12.0%+17.1%$20.61B$2.96B31.437,600Trending NewsAnalyst ForecastILMNIllumina4.8682 of 5 stars$97.15-3.6%$127.39+31.1%-15.9%$15.38B$4.37B-16.009,030Trending NewsAnalyst ForecastTECHBio-Techne4.8563 of 5 stars$51.53-3.0%$72.00+39.7%-29.1%$8.08B$1.16B62.843,100Positive NewsAnalyst ForecastCRLCharles River Laboratories International4.5605 of 5 stars$153.93-2.0%$171.85+11.6%-24.2%$7.56B$4.05B-236.8220,100Positive NewsAnalyst UpgradeBRKRBruker4.8809 of 5 stars$41.27-2.8%$52.89+28.2%-31.3%$6.25B$3.37B79.3711,396High Trading VolumePACBPacific Biosciences of California1.8382 of 5 stars$1.47-8.1%$2.06+40.2%-2.0%$441.13M$152.36M-0.53730News CoverageGap DownHBIOHarvard Bioscience4.2591 of 5 stars$0.44-2.2%$3.00+577.2%-86.4%$19.59M$94.14M-0.34490Trending NewsTMOThermo Fisher Scientific4.9925 of 5 stars$418.76-2.5%$604.05+44.2%-19.8%$158.08B$42.88B24.56125,000Trending NewsDividend AnnouncementAnalyst ForecastAnalyst RevisionAAgilent Technologies4.7491 of 5 stars$119.21-1.8%$140.92+18.2%-5.7%$33.86B$6.51B29.4317,900Analyst Forecast Related Companies and Tools Related Companies Mettler-Toledo International Alternatives Waters Alternatives Illumina Alternatives Bio-Techne Alternatives Charles River Laboratories International Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Agilent Technologies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BIO) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
